24 research outputs found

    The effects of quercetin on oxidative stress resistance and physiological responses in olive flounder, Paralichthys olivaceus

    Get PDF
    ์–ด๋ฅ˜๋Š” ๋…์„ฑ ๋ฐ ์—ผ๋ถ„๋“ฑ๊ณผ ๊ฐ™์€ ์™ธ๋ถ€ ์ธ์ž์— ์˜ํ•œ ์ŠคํŠธ๋ ˆ์Šค๋Š” ์ฒด๋‚ด์—์„œ ์œ ํ•ด์‚ฐ์†Œ์ธ reactive oxygen species (ROS)๋ฅผ ์ƒ์„ฑ&#8228์ฆ๊ฐ€์‹œ์ผœ ์‚ฐํ™” ์ŠคํŠธ๋ ˆ์Šค๋ฅผ ์œ ๋ฐœ์‹œํ‚จ๋‹ค. ๋”ฐ๋ผ์„œ ์ƒ๋ฌผ์ฒด๋Š” ROS์— ์˜ํ•œ ํ•ญ์‚ฐํ™” ์ŠคํŠธ๋ ˆ์Šค๋กœ๋ถ€ํ„ฐ ์ž์‹ ์„ ๋ณดํ˜ธํ•˜๊ณ , ํ•ญ์ƒ์„ฑ์„ ์œ ์ง€ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ํ•ญ์‚ฐํ™” ๋ฐฉ์–ด๊ธฐ์ž‘์„ ๊ฐ€์ง€๊ณ  ์žˆ๋Š”๋ฐ ํ•ญ์‚ฐํ™” ๋ฐฉ์–ด๊ธฐ์ž‘์— ๊ด€์—ฌํ•˜๋Š” ๋Œ€ํ‘œ์ ์ธ ํ•ญ์‚ฐํ™” ํšจ์†Œ๋กœ๋Š” superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) ๋ฐ glutathione S-transferase (GST)๋“ฑ์ด ์กด์žฌํ•˜๋ฉฐ, ํ•ญ์‚ฐํ™”์ œ๋กœ๋Š” Metallothionein (MT), vitamin C ๋ฐ E ๋“ฑ์ด ํ•ญ์‚ฐํ™” ์ž‘์šฉ์„ ํ•˜๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ROS ์ œ๊ฑฐ๋Šฅ์ด ์šฐ์ˆ˜ํ•œ ์ฒœ์—ฐ ํ•ญ์‚ฐํ™”์ œ์ž„๊ณผ ๋™์‹œ์— ๋ฉด์—ญ ๋ฐ ํ˜ธ๋ฅด๋ชฌ ์ฆ์ง„ ๋“ฑ ์ƒ๋ฆฌํ•™์ ์œผ๋กœ ๋›ฐ์–ด๋‚˜๋‹ค๊ณ  ์•Œ๋ ค์ ธ ์žˆ๋Š” ํ€˜๋ฅด์„ธํ‹ด์„ ๋„™์น˜์—๊ฒŒ ๊ณต๊ธ‰ํ•œ ํ›„ ๋…์„ฑ๋ฌผ์งˆ์ธ Cd ๋ฐ ์ €์—ผ๋ถ„์— ๋…ธ์ถœ์‹œ์ผœ ํ•ญ์‚ฐํ™” ํšจ์†Œ์ธ SOD์™€ CAT์˜ ๋ฐœํ˜„๊ณผ ํ™œ์„ฑ ๋ณ€ํ™”๋ฅผ ์กฐ์‚ฌํ•˜์˜€์œผ๋ฉฐ, ROS์˜ ์ผ์ข…์ธ H2O2๋†๋„, ์ง€์งˆ ๊ณผ์‚ฐํ™”(lipid peroxidation, LPO) ์ •๋„๋ฅผ ์ธก์ •ํ•˜์˜€๋‹ค. ํ€˜๋ฅด์„ธํ‹ด์„ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ์™€ ์ผ๋ฐ˜ ์‚ฌ๋ฃŒ๋ฅผ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ๋ฅผ Cd๊ณผ ์ €์—ผ๋ถ„์— ๋…ธ์ถœ์‹œํ‚จ ํ›„ ํ•ญ์‚ฐํ™” ํšจ์†Œ์ธ SOD์™€ CAT ๋ฐœํ˜„๋Ÿ‰์„ quantitative real-time PCR (QPCR)์„ ์ด์šฉํ•˜์—ฌ ๋ถ„์„ํ•œ ๊ฒฐ๊ณผ, ํ€˜๋ฅด์„ธํ‹ด์„ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ์—์„œ ์ผ๋ฐ˜ ์‚ฌ๋ฃŒ๋ฅผ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ๋ณด๋‹ค ๋ฐœํ˜„๋Ÿ‰์ด ๋‚ฎ์•˜์œผ๋ฉฐ, SOD์™€ CAT ํ™œ์„ฑ ๋˜ํ•œ ๋‚ฎ์€ ๊ฐ’์„ ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค. ์ด๋ฅผ ๋’ท๋ฐ›์นจํ•˜๋Š” ๊ฒฐ๊ณผ๋กœ ํ˜ˆ์žฅ H2O2 ๋†๋„ ๋˜ํ•œ ํ€˜๋ฅด์„ธํ‹ด์„ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ์—์„œ ๋” ๋‚ฎ์€ ์ˆ˜์น˜๊ฐ’์„ ๋ณด์˜€๋‹ค. ์ด์™€ ๊ฐ™์ด ์ƒ์„ฑ๋œ ROS๋Š” ์ง€์งˆ ๊ณผ์‚ฐํ™”๋ฅผ ์ผ์œผ์ผœ ์„ธํฌ๋ฅผ ์†์ƒ์‹œํ‚จ๋‹ค๊ณ  ์•Œ๋ ค์ ธ ์žˆ์–ด, ๋ณธ ์—ฐ๊ตฌ์—์„œ๋„ ํ€˜๋ฅด์„ธํ‹ด์„ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ๋ฅผ Cd๊ณผ ์ €์—ผ๋ถ„์— ๋…ธ์ถœ์‹œํ‚จ ํ›„ ์ธก์ •ํ•œ ๊ฒฐ๊ณผ LPO ์ •๋„๊ฐ€ ์ผ๋ฐ˜ ์‚ฌ๋ฃŒ๋ฅผ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ์— ๋น„ํ•˜์—ฌ ๋” ๋‚ฎ์€ ๊ฐ’์„ ๋ณด์—ฌ, ํ€˜๋ฅด์„ธํ‹ด์— ์˜ํ•ด ์ œ๊ฑฐ๋œ ROS๋กœ ์ธํ•˜์—ฌ ์ง€์งˆ ๊ณผ์‚ฐํ™” ์ •๋„๊ฐ€ ๋‚ฎ์Œ์„ ๋ณด์—ฌ์ฃผ๊ณ  ์žˆ๋‹ค. ๋ง๋ถ™์—ฌ ํ€˜๋ฅด์„ธํ‹ด์˜ ํ•ญ์‚ฐํ™” ๋Šฅ๋ ฅ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๋ฉด์—ญ๋Šฅ์„ ํŒŒ์•…ํ•˜๊ธฐ ์œ„ํ•ด ํ€˜๋ฅด์„ธํ‹ด์„ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ์˜ ์ฒด๋‚ด lysozyme ํ™œ์„ฑ์„ ์ธก์ •ํ•œ ๊ฒฐ๊ณผ ์ผ๋ฐ˜ ์‚ฌ๋ฃŒ๋ฅผ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ๋ณด๋‹ค ๋” ๋†’์€ ๊ฐ’์„ ๋ณด์—ฌ ํ€˜๋ฅด์„ธํ‹ด์ด ์ฒด๋‚ด ๋ฉด์—ญ๋Šฅ๋„ ํ–ฅ์ƒ์‹œํ‚จ๋‹ค๋Š” ์‚ฌ์‹ค์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ์œผ๋ฉฐ, ํ˜ธ๋ฅด๋ชฌ ์ฆ์ง„ ํšจ๊ณผ๋ฅผ ์•Œ์•„๋ณด๊ธฐ ์œ„ํ•˜์—ฌ T3 ๋†๋„๋ฅผ ์ธก์ •ํ•œ ๊ฒฐ๊ณผ ์ผ๋ฐ˜ ์‚ฌ๋ฃŒ๋ฅผ ๊ณต๊ธ‰ํ•œ ์‹คํ—˜๊ตฌ๋ณด๋‹ค ๋†’์€ ๊ฐ’์„ ๋ณด์—ฌ ํ€˜๋ฅด์„ธํ‹ด์ด ์ฒด๋‚ด ๋Œ€์‚ฌ ์ž‘์šฉ ์ด‰์ง„์„ ์œ„ํ•œ ํ˜ธ๋ฅด๋ชฌ ์ฆ์ง„์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์นœ๋‹ค๋Š” ๊ฒƒ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค.Contents i List of Table iii List of Figures iv Abstract (in Korean) v I. General Introduction 1 II. Experiment 1 3 Abstract 3 1. Introduction 4 2. Materials and methods 7 2.1. Experimental fish and conditions 7 2.2. Experimental diets 7 2.3. Plasma lysozyme activity and T3 analysis 10 2.4. Cd exposure 10 2.5. Quantitative PCR (QPCR) 11 2.6. SOD and CAT activity analysis 12 2.7. H2O2 assay 13 2.8. LPO assay 13 2.9. Statistical analysis 14 3. Results 15 3.1. Plasma lysozyme activity and T3 analysis 15 3.2. QPCR for SOD and CAT mRNA expression 18 3.3. SOD and CAT activity 22 3.4. H2O2 assay 26 3.5. LPO assay 29 4. Discussion 32 III. Experiment 2 36 Abstract 36 1. Introduction 38 2. Materials and methods 41 2.1. Experimental fish and conditions 41 2.2. Experimental diets 41 2.3. Plasma total cholesterol analysis 42 2.4. Osmotic stress produced by changes of salinity 42 2.5. Quantitative PCR (QPCR) 43 2.6. SOD and CAT activity analysis 44 2.7. H2O2 assay 45 2.8. Plasma lysozyme activity analysis 45 2.9. Plasma osmolality and cortisol analysis 46 2.10. Statistical analysis 46 3. Results 47 3.1. Plasma total cholesterol 47 3.2. SOD and CAT mRNA expression 50 3.3. SOD and CAT activities 54 3.4. H2O2 concentration 58 3.5. Plasma lysozyme activity 61 3.6. Plasma cortisol 64 3.7. Plasma osmolality 67 4. Discussion 70 IV. Conclusion 75 V. Acknowledgement 76 VI. References 7

    Glycyrrhizin inhibits the invasion and metastasis of breast cancer cells via upregulation of expressions of miR-200c and e-cadherin

    Get PDF
    Purpose: To determine the inhibitory effect of glycyrrhizin (GLA) on cell invasion and metastasis in mammary carcinoma cells, and the mechanisms of actions involved.Methods: The effect of GLA at different concentrations on proliferation of breast cancer MDA-MB-231 and BT549 cells was assayed by MTT method. Transwell assay was used to determine the effect of GLA at different concentrations on invasiveness and metastasis of breast cancer MDA-MB-231 and BT549 cells. The influence of LGA on expressions of microRNA-200c and miR-200c was assayed by reverse transcriptase-polymerase chain reaction (RT-PCR).Results: There was no statistically significant difference in cell proliferation amongst cells treated with 5 and 20 ฮผM GLA and untreated breast cancer cells. However, the proliferation of cells treated with 40 ฮผM GLA was significantly reduced (p < 0.05). In the cell invasion and migration experiments, cell population transferred to the base of Transwell chamber in the two cell lines treated with GLA was markedly decreased, relative to cells without GLA treatment, while the number of cells decreased with increase in GLA concentration (p < 0.05). Results from image-pro-plus analysis revealed that the population of cells quantitatively crossing the Transwell compartment membrane decreased with increase in GLA concentration (p < 0.05). The expression of e-cadherin was increased by GLA treatment in a concentration-dependent manner. Moreover, GLA treatment led to significant changes in amounts of miR-200s a, b and c, with changes in miR-200c being the most significant (p < 0.05).Conclusion: GLA suppresses the invasiveness and metastasis of breast cancer MDA-MB-231 and BT549 cells via upregulation of the expressions of miR-200c and e-cadherin. These findings provide a theoretical basis for the development of new breast cancer drugs. Keywords: Glycyrrhiza, GLA, miR-200c, E-cadherin, Inhibition, Breast cancer cells, Invasion, Metastasi

    Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential

    Get PDF
    The apigenin-phospholipid phytosome (APLC) was developed to improve the aqueous solubility, dissolution, in vivo bioavailability, and antioxidant activity of apigenin. The APLC synthesis was guided by a full factorial design strategy, incorporating specific formulation and process variables to deliver an optimized product. The design-optimized formulation was assayed for aqueous solubility, in vitro dissolution, pharmacokinetics, and antioxidant activity. The pharmacological evaluation was carried out by assessing its effects on carbon tetrachloride-induced elevation of liver function marker enzymes in a rat model. The antioxidant activity was assessed by studying its effects on the liver antioxidant marker enzymes. The developed model was validated using the design-optimized levels of formulation and process variables. The physical-chemical characterization confirmed the formation of phytosomes. The optimized formulation demonstrated over 36-fold higher aqueous solubility of apigenin, compared to that of pure apigenin. The formulation also exhibited a significantly higher rate and extent of apigenin release in dissolution studies. The pharmacokinetic analysis revealed a significant enhancement in the oral bioavailability of apigenin from the prepared formulation, compared to pure apigenin. The liver function tests indicated that the prepared phytosome showed a significantly improved restoration of all carbon tetrachloride-elevated rat liver function marker enzymes. The prepared formulation also exhibited antioxidant potential by significantly increasing the levels of glutathione, superoxide dismutase, catalase, and decreasing the levels of lipid peroxidase. The study shows that phospholipid-based phytosome is a promising and viable strategy for improving the delivery of apigenin and similar phytoconstituents with low aqueous solubility

    Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial

    Get PDF
    BackgroundEnzymatically modified isoquercitrin (EMIQ), a water-soluble quercetin, has been shown to intensify muscle hypertrophy in mice. We investigated the effect of EMIQ in supplementary protein powder on athlete body composition.MethodsForty Japanese males who played American football (age: 19.8โ€‰ยฑโ€‰1.4โ€‰years; body height: 174.1โ€‰ยฑโ€‰6.0โ€‰cm; body mass: 75.5โ€‰ยฑโ€‰10.7โ€‰kg) were assigned to a randomized, placebo-controlled, double-blind trial of parallel group. Participants received either EMIQ in whey protein (EW, nโ€‰=โ€‰19) or contrast whey protein (W, nโ€‰=โ€‰20) 6โ€‰days per week over 4โ€‰months. Body composition was assessed using dual-energy X-ray absorptiometry. Markers of oxidative stress, derivatives of reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP), were assessed using a free radical analytical system. Data were analyzed using a univariate and repeated measures general model statistics.ResultsAfter 4โ€‰months, changes in lower limb fat-free mass and muscle mass were significantly greater in the EW group than in the W group (mean change ยฑ95% CI; W: 324.1โ€‰ยฑโ€‰284.3, EW: 950.3โ€‰ยฑโ€‰473.2, pโ€‰=โ€‰0.031, W: 255.7โ€‰ยฑโ€‰288.6, EW: 930.9โ€‰ยฑโ€‰471.5, pโ€‰=โ€‰0.021, respectively). Moreover, the EW group exhibited a significantly higher BAP/d-ROMs ratio, antioxidation index, than the W group after 4โ€‰months (mean change ยฑ SD; W: 8.8โ€‰ยฑโ€‰1.1, EW: 10.3โ€‰ยฑโ€‰2.8; pโ€‰=โ€‰0.028). No significant differences in body mass, lean body mass, fat mass, or lower limb fat mass were observed between the groups.ConclusionIngestion of EMIQ in supplementary protein powder for 4โ€‰months exerts antioxidant effects and increases muscle mass among American football players

    Analysis of phenolic and flavonoids of wild ephedra alata plant extractsby lc/pda and lc/ms and their antioxidant activity

    Get PDF
    Background: Ephedra is among Palestinian medicinal plants that are traditionally used in folkloric medicine for treating many diseases. Ephedra is known to have antibacterial and antioxidant effects. The goal of this study is to evaluate the antioxidant activity of different extracts from the Ephedra alata plant growing wild in Palestine, and to analyze their phenolic and flavonoid constituents by HPLC/PDA and HPLC/MS. Materials and Methods: Samples of the Ephedra alata plant grown wild in Palestine were extracted with three different solvents namely, 100% water, 80% ethanol, and 100% ethanol. The extracts were analyzed for their total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity (AA), as well as phenolic and flavonoids content by HPLC/PDA/MS. Results: The results revealed that the polarity of the extraction solvent affects the TPC, TFC, and AA of extracts. It was found that both TPC and AA are highest for plant extracted with 80% ethanol, followed by 100% ethanol, and finally with 100% water. TFC however was highest in the following order: 100% ethanol > 80% ethanol > water. Pearson correlation indicated that there is a significant correlation between AA and TPC, but there is no correlation between AA and TFC. Simultaneous HPLC-PDA and UHPLC-MS analysis of the ethanolic plant extracts revealed the presence of Luteolin-7-O-glucuronide flavone, Myricetin 3-rhamnoside and some other major polyphenolic compounds that share myricetin skeleton. Conclusion Ephedra alata extract is rich in potent falvonoid glycosidic compounds as revealed by their similar overlaid UV-Vis spectra and UHPLC-MS results. On the basis of these findings, it is concluded that Ephedra alata constitutes a natural source of potent antioxidants that may prevent many diseases and could be potentially used in food, cosmetics, and pharmaceutical products

    Anti-Senescence Therapy

    Get PDF
    The development of therapeutic strategies aimed at the aging process of cells has attracted increasing attention in recent decades due to the involvement of this process in the development of many chronic and age-related diseases. Interestingly, preclinical studies have shown the success of a number of anti-aging approaches in the treatment of a range of chronic diseases. These approaches are directed against aging processes such as oxidative stress, telomerase shortening, inflammation, and deficient autophagy. Many strategies has been shown to be effective in delaying aging, including antiaging strategies based on establishing healthy lifestyle habits and pharmacological interventions aimed at disrupting senescent cells and senescent-associated secretory phenotype. Caloric restriction and intermittent fasting were reported to activate autophagy and reduce inflammation. In turn, immune-based strategies, senolytic agents, and senomorphics mediate their effects either by eliminating senescent cells through inducing apoptosis or by disrupting pathways by which senescent cells mediate their detrimental effects. In addition, given the association of the decline in the regenerative potential of stem cells with aging, many experimental and clinical studies indicate the effectiveness of stem cell transplantation in preventing or slowing the progress of age-related diseases by enhancing the repairing mechanisms and the secretion of many growth factors and cytokines

    Application of nano-curcumin as a natural antimicrobial agent against Gram-positive pathogens

    Get PDF
    Gram-positive bacteria cause various diseases from the superficial skin to deep tissue infections. The capability of causing numerous diseases is due to the production of virulence factors which are tightly regulated by the virulence genes. Various Gram-positive pathogenic bacteria e.g. Staphylococcus, Mycobacterium,ย and Listeriaย are capable of causing lethal infections in humans and animals. Conventional antibiotics, targeted antibiotics, and combinatorial drugs are used as therapeutic agents against Gram-positive pathogens. Due to intricate virulence pathway bacteria readily adopt resistance to available drugs. Therefore, there is need to develop some alternative approaches to combat these infections. Various natural extracts are effective against pathogenic bacteria with or without the available drugs. Curcumin is a natural extract of Curcuma longas rhizome, known as turmeric. Curcumin shows various biological activities such as antimicrobial, antioxidant and anti-inflammatory. It also shows strong antibacterial activity against Gram-positive and few Gram-negative bacteria. Besides all these beneficial applications,ย major drawbacks of curcumin are poor aqueous solubility and less bioavailability. However, drug delivery approaches including nanoformulation are developed to increase its stabilityย in vitroย andย in vivoย settings. The present review article focused on theย translation of potential applications of curcumin in various diseases specifically caused by Gram-positive pathogens. Various methods used for the formulations of curcumin nanoparticles, combinatorial strategies with curcumin nanoparticles and their application in the prevention of infections have been discussed. The present article also discusses the future aspects of curcumin-nanoparticles and its use as an alternative therapeutic approach against pathogens
    corecore